Comparative proteomic analysis of malignant pleural mesothelioma evidences an altered expression of nuclear lamin and filament- related proteins

被引:20
作者
Giusti, Laura [1 ]
Da Valle, Ylenia [1 ]
Bonotti, Alessandra [2 ]
Donadio, Elena [1 ]
Ciregia, Federica [1 ]
Ventroni, Tiziana [1 ]
Foddis, Rudy [3 ]
Giannaccini, Gino [1 ]
Guglielmi, Giovanni [2 ]
Cristaudo, Alfonso [2 ]
Lucacchini, Antonio [1 ]
机构
[1] Univ Pisa, Dept Pharm, I-56126 Pisa, Italy
[2] Hosp Pisa, Operat Unit Occupat Med, Pisa, Italy
[3] Univ Pisa, Dept Translat Res & New Technol Med & Surg, I-56126 Pisa, Italy
关键词
Biomarkers; Lung; Mesothelioma; Prelamin A; C; SERUM MESOTHELIN; CANCER; ANGIOGENESIS; BIOMARKERS; THERAPIES; DIAGNOSIS; UPDATE; VEGF;
D O I
10.1002/prca.201300052
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
PurposeMalignant mesothelioma is a neoplastic disease linked to asbestos exposure whose diagnosis is limited, so detection methods for an early diagnosis and treatment result essential. Here, we compared proteomic profiles of malignant pleural mesothelioma (MPM) and benign biopsies to search potential biomarkers useful in differential diagnosis. Experimental designTissue biopsies were obtained from 53 patients who were subjected to a diagnostic thoracoscopy. 2DE/MS based approach was used for proteomic analysis and protein validation was carried out by Western blot analysis versus benign and lung carcinoma samples. ResultsAmong the proteins identified we confirmed known MPM biomarkers such as calretinin and suggested the new ones as prelamin A/C, desmin, vimentin, calretinin, fructose-bisphosphate aldolase A, myosin regulatory light chain 2, ventricular/cardiac muscle isoform, myosin light chain 3 and myosin light chain 6B. Ingenuity software was used to identify the biological processes to which these proteins belong and to construct a potential network. Conclusions and clinical relevanceOverall, our results suggest potential biomarkers that can be useful in occupational medicine for the early identification of the onset of disease in health surveillance of past asbestos-exposed workers, for monitoring the progress of disease and for assessing the response to treatment.
引用
收藏
页码:258 / 268
页数:11
相关论文
共 37 条
[1]
Improvements and simplifications in in-gel fluorescent detection of proteins using ruthenium II tris-(bathophenanthroline disulfonate): The poor man's fluorescent detection method [J].
Aude-Garcia, Catherine ;
Collin-Faure, Veronique ;
Luche, Sylvie ;
Rabilloud, Thierry .
PROTEOMICS, 2011, 11 (02) :324-328
[2]
Up-Regulation of Bcl-xl by Hepatocyte Growth Factor in Human Mesothelioma Cells Involves ETS Transcription Factors [J].
Cao, Xiaobo ;
Littlejohn, James ;
Rodarte, Charles ;
Zhang, Lidong ;
Martino, Benjamin ;
Rascoe, Philip ;
Hamid, Kamran ;
Jupiter, Daniel ;
Smythe, W. Roy .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (05) :2207-2216
[3]
Anti-angiogenic therapies for malignant pleural mesothelioma [J].
Ceresoli, Giovanni Luca ;
Zucali, Paolo Andrea .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (06) :833-844
[4]
Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes [J].
Chen, Donghong ;
Zhang, Yibing ;
Zhang, Xuhua ;
Li, Jing ;
Han, Bing ;
Liu, Shuo ;
Wang, Lingling ;
Ling, Yuan ;
Mao, Shitao ;
Wang, Xiaoge .
ACTA HISTOCHEMICA, 2013, 115 (02) :128-136
[5]
SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: A molecular epidemiologic case-control study [J].
Cristaudo, A ;
Foddis, R ;
Vivaldi, A ;
Buselli, R ;
Gattini, V ;
Guglielmi, G ;
Cosentino, F ;
Ottenga, F ;
Ciancia, E ;
Libener, R ;
Filiberti, R ;
Neri, M ;
Betta, P ;
Tognon, M ;
Mutti, L ;
Puntoni, R .
CANCER RESEARCH, 2005, 65 (08) :3049-3052
[6]
Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer [J].
Cristaudo, Alfonso ;
Foddis, Rudy ;
Vivaldi, Agnese ;
Guglielmi, Giovanni ;
Dipalma, Nicola ;
Filiberti, Rosangela ;
Neri, Monica ;
Ceppi, Marcello ;
Uzzi, Michela Pagan ;
Ivaldi, Gian Paolo ;
Mencoboni, Manlio ;
Canessa, PierAlclo ;
Ambrosino, Nicolino ;
Chella, Antonio ;
Mutti, Luciano ;
Puntoni, Riccardo .
CLINICAL CANCER RESEARCH, 2007, 13 (17) :5076-5081
[7]
Combined Serum Mesothelin and Plasma Osteopontin Measurements in Malignant Pleural Mesothelioma [J].
Cristaudo, Alfonso ;
Bonotti, Alessandra ;
Simonini, Silvia ;
Vivaldi, Agnese ;
Guglielmi, Giovanni ;
Ambrosino, Nicolino ;
Chella, Antonio ;
Lucchi, Marco ;
Mussi, Alfredo ;
Foddis, Rudy .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) :1587-1593
[8]
Davies BSJ, 2011, NUCLEUS-PHILA, V2, P4, DOI [10.1093/hmg/ddq158, 10.4161/nucl.2.1.13723]
[9]
Angiogenesis is an independent prognostic factor in malignant mesothelioma [J].
Edwards, JG ;
Cox, G ;
Andi, A ;
Jones, JL ;
Walker, RA ;
Waller, DA ;
O'Byrne, KJ .
BRITISH JOURNAL OF CANCER, 2001, 85 (06) :863-868
[10]
Fine-needle aspiration of thyroid nodules: Proteomic analysis to identify cancer biomarkers [J].
Giusti, Laura ;
Iacconi, Pietro ;
Ciregia, Federica ;
Giannaccini, Gino ;
Donatini, Gian Luca ;
Basolo, Fulvio ;
Miccoli, Paolo ;
Pinchera, Aldo ;
Lucacchini, Antonio .
JOURNAL OF PROTEOME RESEARCH, 2008, 7 (09) :4079-4088